Pharmacokinetics and modeling of quercetin and metabolites

Pharmaceutical Research

Volumn 22, Issue 6, 2005, Pages 892-901

  Chen, Xiao ^a,b   Yin, Ophelia Q P ^a   Zuo, Zhong ^a   Chow, Moses S S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Absorption, gut and liver first pass effect; Metabolism; Pharmacokinetic model; Quercetin

Indexed keywords

DRUG METABOLITE; GLUCURONIDE; METHYL GROUP; QUERCETIN; QUERCETIN DERIVATIVE; SULFATE;

ANIMAL EXPERIMENT; ARTICLE; BILE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DISPOSITION; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; ENTEROHEPATIC CIRCULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE; LIVER; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANIMALS; BILE; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGESTIVE SYSTEM; ELECTROCHEMISTRY; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; LIVER; LIVER CIRCULATION; MALE; MODELS, BIOLOGICAL; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS;

EID: 21244465966     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-005-4584-1     Document Type: Article

References (32)

1. A. Crozier M. E. J. Lean M. S. McDonald C. Black 1997 Quantitative analysis of the flavonoid content of commercial tomatoes, onions, lettuce, and celery J. Agric. Food Chem. 45 590 595
2. L. Bravo 1998 Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance Nutr. Rev. 56 317 333
3. W. Zheng S. Y. Wang 2001 Antioxidant activity and phenolic compounds in selected herbs J. Agric. Food Chem. 49 5165 5470
4. M. G. L. Hertog P. C. H. Hollman 1996 Potential health effects of the dietary flavonol quercetin Eur. J. Clin. Nutr. 50 63 71
5. J. V. Formica W. Regelson 1995 Review of the biology of quercetin and related bioflavonoids Food Chem. Toxicol. 33 1061 1080
6. D. A. Shoskes S. I. Zeitlin A. Shahed J. Rajfer 1999 Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial Urology 54 960 963
7. F. Katske D. A. Shoskes M. Sender R. Poliakin K. Gagliano J. Rajfer 2001 Treatment of interstitial cystitis with a quercetin supplement Tech. Urol. 7 44 46
8. E. U. Graefe H. Derendorf M. Veit 1999 Pharmacokinetics and bioavailability of the flavonol quercetin in humans Int. J. Clin. Pharmacol. Ther. 37 219 233
9. P. Ader A. Wessmann S. Wolffram 2000 Bioavailability and metabolism of the flavonol quercetin in the pig Free Radic. Biol. Med. 28 1056 1067
10. E. J. Oliveira D. G. Watson M. H. Grant 2002 Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma Xenobiotica 32 279 287
11. Y. Liu Y. Liu Y. Dai L. Xun M. Hu 2003 Enteric disposition and recycling of flavonoids and ginkgo flavonoids J. Altern. Complement. Med. 9 631 640
12. J. A. Conquer G. Maiani E. Azzini A. Raguzzini B. J. Holub 1998 Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects J. Nutr. 128 593 597
13. J. Nishigaki S. Suzuki J. Yui A. Shigematsu 1995 Distribution volume of three 99mTc-labeled compounds in the rat liver with time after intraportal and intravenous injections Biol. Pharm. Bull. 18 1705 1709
14. J. Nishigaki Y. Suzuki A. Shigematsu 1998 A novel method for measuring the hepatic first-pass effect and metabolic rate of L-3,4-dihydroxyphenylalanine (DOPA), diazepam and inulin in rat liver Biol. Pharm. Bull. 21 735 740
15. J. F. Marier P. Vachon A. Gritsas J. Zhang J. P. Moreau M. P. Ducharme 2002 Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model J. Pharmacol. Exp. Ther. 302 369 373
16. S. Ueda K. Yamaoka T. Nakagawa 1999 Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference J. Pharm. Pharmacol. 51 585 589
17. D. J. Hoffman T. Seifert A. Borre H. N. Nellans 1995 Method to estimate the rate and extent of intestinal absorption in conscious rats using an absorption probe and portal blood sampling Pharm. Res. 12 889 894
18. I. Erlund G. Alfthan H. Siren K. Ariniemi A. Aro 1999 Validated method for the quantitation of quercetin from human plasma using high-performance liquid chromatography with electrochemical detection J. Chromatogr. B Biomed. Sci. Appl. 727 179 189
19. Y. C. Hou P. D. Chao H. J. Ho C. C. Wen S. L. Hsiu 2003 Profound difference in pharmacokinetics between morin and its isomer quercetin in rats J. Pharm. Pharmacol. 55 199 203
20. L. B. Sheiner S. L. Beal 1981 Some suggestions for measuring predictive performance J. Pharmacokinet. Biopharm. 9 503 512
21. C. Manach O. Texier C. Morand V. Crespy F. Regerat C. Demigne C. Remesy 1999 Comparison of the bioavailability of quercetin and catechin in rats Free Radic. Biol. Med. 27 1259 1266
22. C. Manach C. Morand V. Crespy C. Demigne O. Texier F. Regerat C. Remesy 1998 Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties FEBS Lett. 426 331 336
23. C. Morand V. Crespy C. Manach C. Besson C. Demigne C. Remesy 1998 Plasma metabolites of quercetin and their antioxidant properties Am. J. Physiol. 275 R212 R219
24. 14C- quercetin in the ACI rat Jpn. J. Exp. Med. 53 41 50
25. R. Gugler M. Leschik H. J. Dengler 1975 Disposition of quercetin in man after single oral and intravenous doses Eur. J. Clin. Pharmacol. 9 229 234
26. D. R. Ferry A. Smith J. Malkhandi D. W. Fyfe P. G. de Takats D. Anderson J. Baker D. J. Kerr 1996 Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin. Cancer Res. 2 659 668
27. T. Walle U. K. Walle P. V. Halushka 2001 Carbon dioxide is the major metabolite of quercetin in humans J. Nutr. 131 2648 2652
28. A. R. Rechner G. Kuhnle P. Bremner G. P. Hubbard K. P. Moore C. A. Rice-Evans 2002 The metabolic fate of dietary polyphenols in humans Free Radic. Biol. Med. 33 220 235
29. H. P. Noteborn E. Jansen S. Benito M. J. Mengelers 1997 Oral absorption and metabolism of quercetin and sugar-conjugated derivatives in specific transport systems Cancer Lett. 114 175 177
30. K. A. Khaled Y. M. El-Sayed B. M. Al-Hadiya 2003 Disposition of the flavonoid quercetin in rats after single intravenous and oral doses Drug Dev. Ind. Pharm. 29 397 403
31. P. C. Hollman J. M. van Trijp M. J. Mengelers J. H. de Vries M. B. Katan 1997 Bioavailability of the dietary antioxidant flavonol quercetin in man Cancer Lett. 114 139 140
32. J. M. Van Den Hof 1998 Structural identifiability of linear compartmental system IEEE Trans. Automat. Contr. 43 800 818